Screening HIV-positive pregnant women for antiretroviral therapy: Utility of self-reported symptoms

International Journal of STD and AIDS

Volumn 17, Issue 2, 2006, Pages 112-115

  Nguyen, Ruby H N ^a,g   Gange, Stephen J ^b   Serwadda, David ^c   Kigozi, Godfrey ^c   Kiwanuka, Noah ^c   Sewankambo, Nelson K ^c   Wabwire Mangen, Fred ^c   Quinn, Thomas C ^d,e   Wawer, Maria ^f   Gray, Ronald H ^b  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c MAKERERE UNIVERSITY   (Uganda)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^f Columbia University ^*  (United States)

^g Bloomberg School of Public Health ^*  (United States)

Author keywords

ART; HIV; Pregnant; Symptomatology; Viral load

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ACUTE DIARRHEA; ADULT; ARTICLE; BLOODY DIARRHEA; CANDIDIASIS; CD4 LYMPHOCYTE COUNT; CHRONIC DIARRHEA; COUGHING; FEMALE; FEVER; HERPES; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALARIA; PREGNANCY; PREGNANT WOMAN; PRIORITY JOURNAL; PRURITUS; RASH; SCREENING; SELF REPORT; SENSITIVITY AND SPECIFICITY; SWELLING; SYMPTOM; TUBERCULOSIS; UGANDA; VIRUS LOAD; WEIGHT REDUCTION; WORLD HEALTH ORGANIZATION;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; MASS SCREENING; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANT WOMEN; VIRAL LOAD;

EID: 33644529994     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/095646206775455801     Document Type: Article

References (12)

1. Rosenfield A, Figdor E. Where is the M in MTCT? The broader issues in mother-to-child transmission of HIV. Am J Public Health 2001;91:703-4
2. Mitka M. MTCT-Plus program has two goals: end maternal HIV transmission + treat mothers. JAMA 2002;288:153-4
3. UNAIDS/WHO. Emergency scale-up of antiretroviral therapy in resource-limited settings: technical and operational recommendations to achieve 3 by 5. Report of the WHO/UNAIDS International Consensus Meeting on Technical and Operational Recommendations for Emergency Scaling-up of Antiretroviral Therapy in Resource-Limited Settings, 18-21 November 2003 Geneva, Switzerland: World Health Organization, 2003
4. UNAIDS/WHO. AIDS Epidemic Update: 2004. Geneva, Switzerland: UNAIDS/WHO, 2004
5. US Department of Health and Human Services. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. Washington, DC, 2004
6. Gray R, Wawer M, Serwadda D, et al. Population-based study of fertility in women with HIV-1 infection in Uganda. Lancet 1998;351:98-103
7. Desgrees du Lou A, Msellati P, Yao A, et al. Impaired fertility in HIV-1-infected pregnant women: a clinicbased survey in Abidjan, Cote d'Ivoire, 1997. AIDS 1999;13:517-21
8. van Benthem B, de Vincenzi I, Delmas M, Larsen C, van den Hoek A, Prins M. Pregnancies before and after HIV diagnosis in a European cohort of HIV-infected women. AIDS 2000;14:2171-8
9. Zaba B, Carpenter L, Boerma J, Gregson S, Nakiyingi J, Urassa M. Adjusting antenatal clinic data for imporved estimates of HIV prevalence among women in sub-Saharan Africa. AIDS 2000;14:2741-50
10. Wawer M, Gray R, Sewankambo N, et al. A randomized, community trial of intensive sexually transmitted disease control for AIDS prevention. AIDS 1998;12:1211-25
11. The WHO International Collaborating Group for the Study of the WHO Staging System. Proposed 'World Health Organization staging system for HIV infection and disease': preliminary testing by an international collaborative cross-sectional study. AIDS 1993;7:711-18
12. Lee L, Wortley P, Fleming P, Eldred L, Gray R. Duration of human immunodeficiency virus infection and likelihood of giving birth in a medicaid population in Maryland. Am J Epidemiol 2000;151:1020-8